AI copilot in development guides healthy cooking step-by-step

LOS ANGELES — Researchers at Stanford Medicine are developing an AI cooking copilot to help people make healthy and flavorful meals.
The project is led by Minal Moharir, MD, a clinical assistant professor of medicine, primary care and population health at Stanford Medicine.
Moharir told Healio it is often challenging for patients to change their cooking habits for healthier, plant-forward meals. One reason is the lack of guidance on incorporating cultural preferences. This prompted Moharir to launch the Nourish project at Stanford Medicine, which aims to develop culturally tailored resources

Q&A: Clearing up perimenopause misconceptions

SAN FRANCISCO — With only about 15 minutes per visit, it is often difficult for physicians to untangle symptoms related to perimenopause, menopause, chronological aging and underlying comorbidities, according to Monica Christmas, MD.
At the annual ACP Internal Medicine Meeting, Christmas offered a presentation on perimenopause to help physicians manage the condition.
Healio spoke with Christmas — an associate professor of OB/GYN, director for the Center for Women’s Integrated Health and director of the Menopause Program at the University of Chicago School of Medicine, and associate medical

Orthopedists face barriers in intimate partner violence screening

Intimate partner violence, defined as abuse or aggression that occurs in an intimate relationship, affects millions of people in the United States each year, according to the CDC.
Intimate partner violence (IPV) can present as emotional violence, physical violence, sexual violence, stalking or psychological aggression, and it can vary in how often it happens and how severe it is. The CDC reports more than 1 in 3 women and 1 in 6 men experience some form of IPV during their lifetimes.
When it comes to diagnosis and treatment of injuries resulting from IPV, the second most common embodiment of

Mixed results for leadless conduction system pacemaker

A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but dislodgement issues have led to a redesign effort, researchers reported at Heart Rhythm 2026.
As Healio previously reported, in a first-in-human study presented at Heart Rhythm 2025, the leadless pacemaker (Aveir CSP, Abbott) attained left bundle branch area pacing capture in five of 10 patients who had a successful implant. Vivek Y. Reddy, MD, director of cardiac arrhythmia services at Mount Sinai Hospital and the Mount Sinai Health System, presented at Heart Rhythm

Goals of care may be key in acute MI, shock mortality

Differences in treatment, not sex, may explain the higher mortality rates observed among women who present with acute myocardial infarction and cardiogenic shock compared with men, a speaker reported.
Among women who did not undergo initial angiography after presenting with acute MI and shock, patient or family preference was cited as the reason for deferral in nearly half of the cases, researchers reported.
Among patients who underwent invasive treatment of acute MI and shock, there were no significant differences between men and women in terms of survival, according to data presented at the

Biological aging associated with some depressive symptoms

Monocyte aging is linked to non-somatic depression symptoms in women both with and without HIV, data published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences show.
“Depression is not a one-size-fits-all disorder. It can look really different from person to person, which is why it's so important to consider varied presentations and not just a clinical label,” Nicole Beaulieu Perez, PhD, RN, PMHNP-BC, an assistant professor at New York University Rory Meyers College of Nursing, said in a press release. “Our study reveals unique biological underpinnings of

Tips for managing weight during menopause

LAS VEGAS — Weight gain is a common concern for women during menopause, and health care professionals should take a comprehensive approach to managing weight in this population, according to a speaker.
According to data published in Mayo Clinic Proceedings in 2025, approximately 80% of midlife women report problems with weight gain, and 20% categorize those problems as severe or very severe. However, Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine in the division of endocrinology, diabetes and metabolism and part of the Precision Medicine for Obesity program at Mayo

MS medications linked to increased risk for UTI, urosepsis

CHICAGO — Several disease-modifying therapies for MS were associated with increased risks for urinary tract infections and urosepsis, according to a speaker at the American Academy of Neurology Annual Meeting.
Immune effects related to these therapies and underlying bladder dysfunction due to MS are the likely drivers behind these associations, Tamara Kaplan, MD, FAAN, assistant professor of neurology, Harvard Medical School, said during her presentation.
Neurogenic bladder dysfunctions are common with MS, with nearly 100% of all patients experiencing bladder symptoms within the first 10 years

VIDEO: Nemolizumab shows efficacy in eczema for children younger than 12 years

DENVER — In this video, Lawrence F. Eichenfield, MD, discusses data presented at the American Academy of Dermatology Annual Meeting on nemolizumab treatment for children younger than 12 years.
Eichenfield said the findings demonstrated ‘very nice’ efficacy rates with nemolizumab (Nemluvio, Galderma) over 16 weeks and the extension period, reducing itch and EASI scores for children aged 2 to 11 years. More studies will be conducted moving forward.
“Remember, this is investigational at this point, not an approved use of nemolizumab. But [it is] really the first younger

Hormone replacement therapy in breast cancer requires dialogue

Nearly every woman with breast cancer has at least one menopausal symptom.
Yet many patients feel their quality-of-life needs frequently go unmet because of safety concerns regarding menopausal hormone therapy (MHT).
“I had a patient whose general practitioner told her he wasn’t prepared to lose his 40-year career by prescribing MHT for her,” Sarah Glynne, MBBS, MRCP, MRCGP, MSc, menopause specialist at The Portland Hospital in London, told Healio. “I had a patient whose oncologist told her she can’t take that [expletive] when she asked about MHT. No discussion. No conversation about benefits